Antithrombotic therapy after mitral valve repair: VKA or aspirin?

The optimal antithrombotic therapy following mitral valve repair (MVr) is still a matter of debate. Therefore, we evaluated the rate of thromboembolic and bleeding complications of two antithrombotic prevention strategies: vitamin K antagonists (VKA) versus aspirin. Consecutive patients who underwen...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Wall, Sake J., Olsthoorn, Jules R., Heuts, Samuel, Klautz, Robert J. M., Tomsic, Anton, Jansen, Evert K., Vonk, Alexander B. A., Sardari Nia, Peyman, Klok, Frederikus A., Huisman, Menno V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182386/
https://www.ncbi.nlm.nih.gov/pubmed/30132244
http://dx.doi.org/10.1007/s11239-018-1724-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182386/
https://www.ncbi.nlm.nih.gov/pubmed/30132244
http://dx.doi.org/10.1007/s11239-018-1724-0

Ejemplares similares